Salute e Benessere

Pulse Oximeter Market to Hit $7.03 Billion by 2032--Redefining Respiratory…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68168578 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68168578 Why is pulse oximetry emerging as a clinical cornerstone in respiratory care? Whether in high-acuity ICUs or home care settings, pulse oximeters provide essential oxygen saturation and heart rate insights. As chronic conditions like COPD and asthma rise globally, portable, wearable, and connected pulse...
PR Newswire
09/07/2025

A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care

RIYADH, Saudi Arabia, July09, 2025(GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition.When the early signs of illness...
Nasdaq GlobeNewswire
09/07/2025

Aktiia's Hilo Band Becomes First Cuffless Blood Pressure Monitor Cleared by FDA…

NEUCHÂTEL, Switzerland, July 9, 2025 /PRNewswire/ -- Aktiia, a pioneer in optical blood pressure monitoring, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for over-the-counter (OTC) use of its cuffless blood pressure monitoring technology. This clearance, granted for Aktiia's G0 Blood Pressure Monitoring System, marks the first time the FDA has cleared a cuffless blood pressure monitor indicated for over-the-counter (OTC) use in the United States…
PR Newswire
09/07/2025

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

Click here to view the custom infographic of the Calidi Biotherapeutics editorial. Clickhere to view the custom infographic of the Calidi Biotherapeutics editorial. Immense Human Toll, Critical Need for Research Cancer continues to be one of the leading global health crises, accounting for roughly one in every six deaths worldwide ( https://ibn.fm/ZzZHC ). Among the most prevalent forms are lung cancer, with 2.2 million new cases and 1.8 million deaths in 2020, followed by breast (2...
PR Newswire
09/07/2025

EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to…

Post-amputation pain is a severely underserved indication, affecting up to 80 percent of amputees in the U.S., with few effective non-opioid treatment options. The Altius® system delivers targeted nerve stimulation through a patient-controlled, on-demand therapy, and is currently the only FDA-approved solution for post-amputation pain. Post-amputation pain is a severely underserved indication, affecting up to 80 percent of amputees in the U.S., with few effective non-opioid treatment options...
PR Newswire
09/07/2025

Erin M. Schuman Wins 2026 Nakasone Award for Discovery on Neural Synapse…

Schuman's groundbreaking research revealed that proteins critical for neuron communication, plasticity and memory storage, are produced locally at synapses, the junctions between neurons. This insight overturns the previous belief that all proteins are made in the cell body and then shipped out to synapses where they function. "HFSPO is thrilled to honor Dr.Erin Schumanas her discovery is influencing the entire field of neuroscience where the focus is increasingly on individual...
PR Newswire
09/07/2025

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform…

"Effectively delivering therapeutics across the blood-brain barrier remains one of the most important challenges in drug discovery," said Robert Baloh, Global Head of Neuroscience, Biomedical Research at Novartis. "We're excited to enter into this agreement with Sironax to fully explore the promise of the BDM platform, leveraging our deep expertise and capabilities in neuroscience to bring forward next-generation therapies for patients in need." "Effectively delivering…
PR Newswire
09/07/2025

Inside information: Orion upgrades full-year outlook for 2025

ORION CORPORATIONSTOCK EXCHANGE RELEASE – INSIDE INFORMATION9 JULY 2025 at 13.00 EEST Inside information: Orion upgrades full-year outlook for 2025 Orion Corporation upgrades the full-year outlook for 2025 both for the part regarding net sales and operating profit. Orion’s product sales and royalty income have increased faster than expected during the first half of 2025, and this good development is anticipated to continue during the remainder of the year. Due to these...
Nasdaq GlobeNewswire
09/07/2025

Smart home pioneer Dreame launches exclusive UK Amazon Prime Day deals with up…

Dreame's Prime Day offers are live now on Amazon here, the official Dreame website, and selected retail channels, with some of the best deals available for just three days until Prime Day ends. Dreame's Prime Day offers are live now on Amazon here , the official Dreame website , and selected retail channels, with some of the best deals available for just three days until Prime Day ends. Dreame X50 Ultra Complete Reduced from £1,199 to £899 Dreame's most advanced robot vacuum...
PR Newswire
09/07/2025

Zentiva and Lupin Sign License and Supply Agreement for TNF alpha inhibitor…

Zentiva will oversee commercialization activities outsideUSAandCanada, predominantly inEuropeand CIS markets, where it will leverage its extensive European commercial infrastructure and regulatory expertise. Lupin will be responsible for the development, manufacturing and supply of the product within the agreed territories. Lupin will undertake commercialization in the remaining regions, includingUSAandCanada. Both parties will invest in the development of the...
PR Newswire
09/07/2025

MEDIPEEL Debuts at Printemps, France's Iconic Beauty Destination

Each participating brand will be given a dedicated "Brand Week," during which they can connect with global shoppers in the central zone of the pop-up stores. MEDIPEEL's Brand Week, scheduled for August 25 to August 31, will feature diverse on-site events to highlight its brand identity. Beyond gifts with purchase, MEDIPEEL will also host a roulette event offering its hero product as a prize. Visitors can enjoy an experience zone with Young Cica character HOKA, as well as branding…
PR Newswire
09/07/2025

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of…

REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the expansion of its capacity for assembly and packaging with the acquisition of Ivers-Lee Group (“Ivers-Lee”), a family owned business with headquarters in Burgdorf, Switzerland specializing in providing high-quality assembly and packaging services for the pharmaceutical…
Nasdaq GlobeNewswire
09/07/2025

Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine…

The Company's discovery platform combines rational drug design with radiochemistry to create novel small molecule radioligands that overcome current limitations in radiopharmaceutical development. Its three-pillar platform includes first-in-class covalent targeting strategies, designed to optimize tumor residence time, while ensuring rapid systemic clearance – improving precision, safety, and efficacy. Two additional proprietary approaches further support compound differentiation and improve…
PR Newswire
09/07/2025

SKF to publish Q2 report on 18 July

To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers:Link to web event: https://www.investis-live.com/skf/682b4fb3b64a85001524efa7/nqrtySweden: +46 8 5051 0031UK / International: +44 207 107 0613 To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers: Link to web event:https://www.investis-live.com/skf/682b4fb3b64a85001524efa7/nqrty Sweden : +46 8 5051 0031 UK /…
PR Newswire
09/07/2025

SciBase Launches Nevisense Pilot at Leading University in Southeast Florida

The University is globally recognized as leaders in the diagnosis and treatment of dermatological conditions and disorders of the skin. Their faculty includes a number of notable academics, including Nobel Prize recipients and globally recognized experts across nearly every academic discipline, and is classified among "Doctoral Universities: Very High Research Activity". In addition to research, the University maintains several university-wide research centers, including a data center…
PR Newswire
09/07/2025

Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial…

PS-002, Purespring’s lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathyIND clearance follows the granting of European Medicine Agency (EMA) orphan drug designation in April 2025First patient expected to be enrolled in 2025London – 9 July 2025 -Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announces that the U.S. Food and Drug Administration (FDA) has...
Nasdaq GlobeNewswire
09/07/2025

XRP Healthcare Appoints Capital Markets Executive Anna Skowron as Chief…

XRP Healthcare operates on an international scale, with a strategic focus on Sub-Saharan Africa. The company has acquired a chain of pharmacies in Uganda, where it is actively integrating healthcare infrastructure with its proprietary XRPH AI App — a multilingual, AI-powered digital health assistant currently being used by communities across the continent. XRP Healthcare operates on an international scale, with a strategic focus on Sub-Saharan Africa. The company has acquired a chain of...
PR Newswire
09/07/2025

GORE ANNOUNCES MDR EXPANDED INDICATION FOR THE GORE® VIABAHN® VBX BALLOON…

"This is a landmark indication for a stent graft, equipping physicians with an on-label solution for more patients in complex pathologies," said Prof. Luca Bertoglio, Associate Professor, Vascular Surgery, Spedali Civili Brescia and Coordinating Investigator of the EMBRACE Registry. "This is a landmark indication for a stent graft, equipping physicians with an on-label solution for more patients in complex pathologies," said Prof.Luca Bertoglio, Associate Professor, Vascular…
PR Newswire
09/07/2025

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific…

The Phase 1/2 first-in-human, open-label clinical study is designed to assess the safety, tolerability, and preliminary clinical activity of AVZO-1418/DB-1418 as a single agent and in combination therapy in patients with advanced solid tumors. The Phase 1/2 first-in-human, open-label clinical study is designed to assess the safety, tolerability, and preliminary clinical activity of AVZO-1418/DB-1418 as a single agent and in combination therapy in patients with advanced solid tumors. About...
PR Newswire
09/07/2025

Bispecifics/BiTE Market Anticipates Impressive Growth Trajectory During the…

Key Takeaways from the Bispecifics/BiTE Market Report Key Takeaways from the Bispecifics/BiTE Market Report Discover which indication is expected to grab the major bispecifics/BiTE market share @ Bispecifics/BiTE Market Report Bispecifics/BiTE Market Dynamics The bispecific antibody and BiTE market is experiencing strong momentum, driven byrapid advancements in immuno-oncology and increasing demand for precision biologics. These modalities are designed to simultaneously bind...
PR Newswire
08/07/2025

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et…

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025-GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the liquidity account as of...
Nasdaq GlobeNewswire
08/07/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 27- 2025

Aggregated presentation by day and by market Statement of transactions in own shares from June 30th to July 4th 2025 Name of the issuerIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1130/06/2025FR0010259150 2 847...
Nasdaq GlobeNewswire
08/07/2025

Technimark Unveils New Brand Identity: "We Make What Makes Life Better"

"This is more than a new look — it's a statement of who we are today and where we're going tomorrow," said Kris Peavy, Chief Commercial Officer and President of Healthcare. "This is more than a new look — it's a statement of who we are today and where we're going tomorrow," saidKris Peavy, Chief Commercial Officer and President of Healthcare. "Our new brand identity reflects our value as a true solutions partner. We work side-by-side with our customers to overcome…
PR Newswire
08/07/2025

Report on Carbios’ liquidity contract with Natixis ODDO BHF

PRESS RELEASE REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716)Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 08 July 2025 (18:00 CEST).CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, reports today about the liquidity contract entrusted to Natixis ODDO BHF.As of June 30, 2025, the following assets...
Nasdaq GlobeNewswire
08/07/2025
Altri  Comunicati